Global In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Research Report 2023

Publication ID:

PB502231592

Publication Date:

February 6, 2023

Pages:

102

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Related products that used to control quality of In Vitro Diagnostics.
Highlights
The global In Vitro Diagnostics (IVD) Quality Control market was valued at US$ 809.1 million in 2022 and is anticipated to reach US$ 956.9 million by 2029, witnessing a CAGR of 2.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving the quality control market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostics (IVD) Quality Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostics (IVD) Quality Control.
The In Vitro Diagnostics (IVD) Quality Control market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In Vitro Diagnostics (IVD) Quality Control market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Diagnostics (IVD) Quality Control companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Siemens Healthcare GmbH
Roche Diagnostics
Abbott
Abbott Laboratories Inc.
Bio-Techne
Hologic Inc.
Qiagen N.V.
Bio-Rad Laboratories Inc.
Quidel Corporation
Becton
Dickinson and Company(BD)
BioMerieux Inc.
Sysmex Corporation
Sero AS
Thermo Fisher Scientific Inc.
Segment by Type
Quality Controls
Data Management
Quality Assurance Services
Segment by Application
Clinical Chemistry
Immunochemistry
Hematology
Molecular Diagnostics
Coagulation
Microbiology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostics (IVD) Quality Control companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Quality Controls
1.2.3 Data Management
1.2.4 Quality Assurance Services
1.3 麻豆原创 by Application
1.3.1 Global In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Clinical Chemistry
1.3.3 Immunochemistry
1.3.4 Hematology
1.3.5 Molecular Diagnostics
1.3.6 Coagulation
1.3.7 Microbiology
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Perspective (2018-2029)
2.2 In Vitro Diagnostics (IVD) Quality Control Growth Trends by Region
2.2.1 Global In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 In Vitro Diagnostics (IVD) Quality Control Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 In Vitro Diagnostics (IVD) Quality Control Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Dynamics
2.3.1 In Vitro Diagnostics (IVD) Quality Control Industry Trends
2.3.2 In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Drivers
2.3.3 In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Challenges
2.3.4 In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostics (IVD) Quality Control Players by Revenue
3.1.1 Global Top In Vitro Diagnostics (IVD) Quality Control Players by Revenue (2018-2023)
3.1.2 Global In Vitro Diagnostics (IVD) Quality Control Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Diagnostics (IVD) Quality Control Revenue
3.4 Global In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Concentration Ratio
3.4.1 Global In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics (IVD) Quality Control Revenue in 2022
3.5 In Vitro Diagnostics (IVD) Quality Control Key Players Head office and Area Served
3.6 Key Players In Vitro Diagnostics (IVD) Quality Control Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostics (IVD) Quality Control 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostics (IVD) Quality Control Breakdown Data by Type
4.1 Global In Vitro Diagnostics (IVD) Quality Control Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global In Vitro Diagnostics (IVD) Quality Control Forecasted 麻豆原创 Size by Type (2024-2029)
5 In Vitro Diagnostics (IVD) Quality Control Breakdown Data by Application
5.1 Global In Vitro Diagnostics (IVD) Quality Control Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global In Vitro Diagnostics (IVD) Quality Control Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size (2018-2029)
6.2 North America In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Country (2018-2023)
6.4 North America In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size (2018-2029)
7.2 Europe In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Country (2018-2023)
7.4 Europe In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size (2018-2029)
9.2 Latin America In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Country (2018-2023)
9.4 Latin America In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa In Vitro Diagnostics (IVD) Quality Control 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens Healthcare GmbH
11.1.1 Siemens Healthcare GmbH Company Detail
11.1.2 Siemens Healthcare GmbH Business Overview
11.1.3 Siemens Healthcare GmbH In Vitro Diagnostics (IVD) Quality Control Introduction
11.1.4 Siemens Healthcare GmbH Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.1.5 Siemens Healthcare GmbH Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Detail
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics In Vitro Diagnostics (IVD) Quality Control Introduction
11.2.4 Roche Diagnostics Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.2.5 Roche Diagnostics Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott In Vitro Diagnostics (IVD) Quality Control Introduction
11.3.4 Abbott Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Abbott Laboratories Inc.
11.4.1 Abbott Laboratories Inc. Company Detail
11.4.2 Abbott Laboratories Inc. Business Overview
11.4.3 Abbott Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Introduction
11.4.4 Abbott Laboratories Inc. Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.4.5 Abbott Laboratories Inc. Recent Development
11.5 Bio-Techne
11.5.1 Bio-Techne Company Detail
11.5.2 Bio-Techne Business Overview
11.5.3 Bio-Techne In Vitro Diagnostics (IVD) Quality Control Introduction
11.5.4 Bio-Techne Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.5.5 Bio-Techne Recent Development
11.6 Hologic Inc.
11.6.1 Hologic Inc. Company Detail
11.6.2 Hologic Inc. Business Overview
11.6.3 Hologic Inc. In Vitro Diagnostics (IVD) Quality Control Introduction
11.6.4 Hologic Inc. Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.6.5 Hologic Inc. Recent Development
11.7 Qiagen N.V.
11.7.1 Qiagen N.V. Company Detail
11.7.2 Qiagen N.V. Business Overview
11.7.3 Qiagen N.V. In Vitro Diagnostics (IVD) Quality Control Introduction
11.7.4 Qiagen N.V. Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.7.5 Qiagen N.V. Recent Development
11.8 Bio-Rad Laboratories Inc.
11.8.1 Bio-Rad Laboratories Inc. Company Detail
11.8.2 Bio-Rad Laboratories Inc. Business Overview
11.8.3 Bio-Rad Laboratories Inc. In Vitro Diagnostics (IVD) Quality Control Introduction
11.8.4 Bio-Rad Laboratories Inc. Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.8.5 Bio-Rad Laboratories Inc. Recent Development
11.9 Quidel Corporation
11.9.1 Quidel Corporation Company Detail
11.9.2 Quidel Corporation Business Overview
11.9.3 Quidel Corporation In Vitro Diagnostics (IVD) Quality Control Introduction
11.9.4 Quidel Corporation Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.9.5 Quidel Corporation Recent Development
11.10 Becton
11.10.1 Becton Company Detail
11.10.2 Becton Business Overview
11.10.3 Becton In Vitro Diagnostics (IVD) Quality Control Introduction
11.10.4 Becton Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.10.5 Becton Recent Development
11.11 Dickinson and Company(BD)
11.11.1 Dickinson and Company(BD) Company Detail
11.11.2 Dickinson and Company(BD) Business Overview
11.11.3 Dickinson and Company(BD) In Vitro Diagnostics (IVD) Quality Control Introduction
11.11.4 Dickinson and Company(BD) Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.11.5 Dickinson and Company(BD) Recent Development
11.12 BioMerieux Inc.
11.12.1 BioMerieux Inc. Company Detail
11.12.2 BioMerieux Inc. Business Overview
11.12.3 BioMerieux Inc. In Vitro Diagnostics (IVD) Quality Control Introduction
11.12.4 BioMerieux Inc. Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.12.5 BioMerieux Inc. Recent Development
11.13 Sysmex Corporation
11.13.1 Sysmex Corporation Company Detail
11.13.2 Sysmex Corporation Business Overview
11.13.3 Sysmex Corporation In Vitro Diagnostics (IVD) Quality Control Introduction
11.13.4 Sysmex Corporation Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.13.5 Sysmex Corporation Recent Development
11.14 Sero AS
11.14.1 Sero AS Company Detail
11.14.2 Sero AS Business Overview
11.14.3 Sero AS In Vitro Diagnostics (IVD) Quality Control Introduction
11.14.4 Sero AS Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.14.5 Sero AS Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Detail
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. In Vitro Diagnostics (IVD) Quality Control Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in In Vitro Diagnostics (IVD) Quality Control Business (2018-2023)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Siemens Healthcare GmbH
Roche Diagnostics
Abbott
Abbott Laboratories Inc.
Bio-Techne
Hologic Inc.
Qiagen N.V.
Bio-Rad Laboratories Inc.
Quidel Corporation
Becton
Dickinson and Company(BD)
BioMerieux Inc.
Sysmex Corporation
Sero AS
Thermo Fisher Scientific Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.